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Mycotoxin binderThe xenoestrogenic mycotoxin zearalenone is a common food contaminant produced by Fusarium strains. The
modifiedmycotoxin zearalenone-14-sulfate (Z14S) is formed inboth fungi andmammals during the biotransfor-
mation of zearalenone. Cyclodextrins (CD) are cyclic oligosaccharideswhich can formhost-guest type complexes
with somemycotoxins, including zearalenone, zearalenols, and zearalenone-14-glucoside. As a result of the com-
plex formation, the fluorescence signal of these mycotoxins strongly increases. Furthermore, CD polymers seem
to be suitable for the extraction of somemycotoxins from aqueous solutions and beverages. In this study, the in-
teraction of Z14S with CDs and soluble CD polymers was examined with fluorescence spectroscopy and molec-
ular modeling. Furthermore, the removal of Z14S from aqueous solution by β-CD bead polymer (BBP) was also
tested. Our results demonstrate the formation of stable Z14S-CD complexes (K = 0.1 to 5.0 × 104 L/mol).
Dimethyl-β-CD (DIMEB) produced themost stable complexes with Z14S at pH 5.0 and 7.4. At pH 10.0, the bind-
ing constant of Z14S-DIMEB complex decreased and quaternary ammonium-β-CD showed similar affinity to-
ward the mycotoxin than DIMEB. In addition, Z14S was successfully removed from aqueous solutions by BBP.
Considering the above-listed observations, besides the parentmycotoxins, some of theirmodified/masked deriv-
atives can also interact with CDs.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Zearalenone is a toxic secondary metabolite of Fusarium species,
which frequently contaminate grains (especially maize) and other
commodities (e.g., fruits, meat, pastry, and beverages) [1,2]. The con-
sumption of zearalenone-contaminated food and feed can result in
the development of reproductive disorders in animals and humans,
due to the xenoestrogenic effect of themycotoxin and its metabolites
[2–4]. Zearalenone is highly biotransformed by mammals, plants,
and fungi, during which reduced (zearalenols, zearalanone, and





. This is an open access article underMycotoxin conjugates produced by plants are designated as masked
mycotoxins, while other compounds formed by structural modifica-
tion of the parent mycotoxins are referred to modified mycotoxins
[5,6]. Zearalenone-14-sulfate (Z14S; also termed as zearalenone-4-
sulfate; Fig. 1) is produced by different strains (e.g., Aspergillus
oryzae, Fusarium and Rhizopus species) as a fungal metabolite or by
sulfotransferase (SULT) enzyme during the phase II metabolism of
zearalenone in mammals [4,5]. Generally, the sulfate conjugation re-
sults in less toxic derivatives, due to the increased hydrophilicity of
the metabolite formed. However, Z14S can be degraded partly to
the more toxic parent compound by the human intestinal
microbiome [7]. Therefore, we need to consider Z14S as a similarly
toxic compound to zearalenone, and should take into consideration
during the health risk assessment of the exposure [5].
Cyclodextrins (CDs) are cyclic glucose oligomers joined through 1–4
glycosidic linkage. CDs possess a lipophilic internal cavity and a hydro-
philic external part, the latter provides them high aqueous solubility
[8,9]. Since CDs can entrap nonpolar molecules in their internal cavity,the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Chemical structure of zearalenone-14-sulfate (Z14S).
2 Z. Faisal et al. / Journal of Molecular Liquids 310 (2020) 113236they are commonly utilized by pharmaceutical, cosmetic, and food in-
dustries. The three most frequently applied CDs are α-, β-, and γ-CDs,
containing six, seven, and eight D-glucopyranose units, respectively
[9]. The complexation of guest molecules by CDs is strongly influenced
by the chemical modification of the host [9,10]. As it has been reported,
CDs can interact with somemycotoxins (and their derivatives), includ-
ing aflatoxins, citrinin, dihydrocitrinone, ochratoxin A, zearalenone,
zearalenols, and zearalenon-14-glucoside [11–17]. Typically, the com-
plex formation of fluorescentmycotoxins with CDs increases their fluo-
rescence signal, which may be beneficial from the analytical point of
view [18,19]. Furthermore, based on previous studies, CD polymers
seem to be suitable for the removal of certain mycotoxins
(e.g., patulin, ochratoxin A, alternariol, zearalenone, and zearalenols)
andmaskedmycotoxins (e.g., zearalenone-14-glucoside) from aqueous
solutions, including beverages (such as fruit juices, wine, or beer)
[17,20–23].
Despite the fact that modified mycotoxins commonly appear in
grains and in other commodities, we have only limited information re-
garding their interactions with CDs. Since the masked mycotoxin
zearalenone-14-glucoside forms complexes with CDs [17], it is reason-
able to hypothesize that other modified mycotoxins may also be
entrapped by CDs. Therefore, in this study, the complex formation of
Z14Swithnative and chemically-modified CDs and soluble CDpolymers
(pH 5.0–10.0) was investigated employing fluorescence spectroscopy
and molecular modeling. Furthermore, the removal of Z14S from aque-
ous solution by insoluble β-cyclodextrin bead polymer (BBP) was also
investigated. Our results demonstrate that, similarly to zearalenone,
Z14S also formed stable complexes with native and chemically-
modified CDs and BBP successfully removed the modified mycotoxin
from aqueous solution.2. Materials and methods
2.1. Reagents
Zearalenone-14-sulfate ammonium salt (Z14S) was obtained from
ASCAGmBh (Berlin, Germany). Z14S stock solution (5000 μM)was pre-
pared in spectroscopic grade ethanol (96 v/v%; Reanal, Budapest,
Hungary) and stored at−20 °C. Cyclodextrins, including β-CD (BCD),
γ-CD (GCD), randomly methylated β-CD (RAMEB), heptakis-2,6-di-O-
methyl-β-cyclodextrin (DIMEB), 6-monodeoxy-6-monoamino-β-
cyclodextrin (MABCD), (2-hydroxy-3-N,N,N-trimethylamino)propyl-
β-cyclodextrin (QABCD), (2-hydroxypropyl)-β-CD (HPBCD),
sulfobutyl-β-cyclodextrin (SBCD), epichlorohydrin cross-linked soluble
BCD polymer (BCD content: 70 m/m%), epichlorohydrin cross-linked
soluble QABCD polymer (QABCD content: 60 m/m%), and insoluble
(water-swellable) β-cyclodextrin bead polymer (BBP; cyclodextrin-
epichlorohydrin cross-linked bead polymer; BCD content: 50 m/m%)
were provided by CycloLab Cyclodextrin Research and Development
Laboratory, Ltd. (Budapest, Hungary).2.2. Spectroscopic measurements
Fluorescence spectra were recorded at 25 °C in the presence of air,
using a Hitachi F-4500 fluorimeter (Tokyo, Japan). In spectroscopic
studies, sodium acetate (0.05 M, pH 5.0), sodium phosphate (0.05 M,
pH 7.4), and sodium borate (0.05 M, pH 10.0) buffers were applied.
Fluorescence emission spectra of Z14S were examined in the presence
of increasing CD concentrations, applying 320 nm excitation
wavelength.
Binding constants (K; unit: L/mol) of Z14S-CD complexes were de-







A K CD½ n ð1Þ
where I0 and I are the fluorescence emission intensity of Z14S in the ab-
sence and presence of CDs, respectively. A is a constant, n is the number
of binding sites, and [CD] is the concentration (unit: L/mol) of the host
molecule.
2.3. Molecular modeling studies
The molecular modeling approach relied on a combination of
pharmacophoric analysis of CD cavity integrated with docking studies
to provide a plausible architecture of binding. The 3D structures of β-
CD, γ-CD, and DIMEB derived from the crystallographic structures re-
corded in the Cambridge Crystallographic Data Center (CCDC) database
(https://www.ccdc.cam.ac.uk/structures) having accession code
WEWTOJ, LAJLALO2, and ZULQAY, respectively. The 3D coordinates of
Z14S were retrieved from PubChem (https://pubchem.ncbi.nlm.nih.
gov; CID = 45359500, accessed on November 21, 2019). The consis-
tency of atom and bond types assignment of Z14S and CDs were
checked with the Sybyl software (version 8.1; www.certara.com), as
previously reported [24]. Z14S was computed in the deprotonated
form and the 3D structure was energetically minimized using Powel al-
gorithm (with a coverage gradient of ≤0.05 kcal/(mol × Å) and a maxi-
mum of 250 iterations) before the analysis, as it has been reported [17].
The description of CD sites was carried out using the Flapsite tool of
the FLAP software (Fingerprint for Ligand And Protein; https://www.
moldiscovery.com) while the GRID algorithm was used to investigate
the corresponding pharmacophoric space [25,26] in agreement with
previous studies [27]. The GOLD software [28] was used to perform all
the docking simulations as it previously proved to be reliable in
predicting the binding architectures of host-guest type complexes
[17,29,30]. GOLD setting reported by Dellafiora and co-workers was
used [29]. As exception, ten poses were generated for each compound
in each CD and the best-scoredpose according to theGOLDScore scoring
function was considered to represent the most probable architecture of
binding, in agreement with previous works [17,31–33].
2.4. Extraction of Z14S from aqueous buffer by BBP
To investigate the removal of Z14S by BBP, the mycotoxin (2 μM in
1.5 mL volume) was incubated with increasing amounts of the bead
polymer (0.0, 1.0, 2.5, 5.0, 10.0, and 20.0 mg/1.5 mL) in sodium acetate
buffer (0.05 M, pH 5.0; 40 min, 1000 rpm, 25 °C). Then BBP was
sedimented by pulse centrifugation (4000g, 6 s, room temperature)
and the mycotoxin content of the supernatant was determined by
high-performance liquid chromatography (HPLC; see in Section 2.5).
Using the same experimental conditions, increasingmycotoxin con-
centrations (0.2, 2.5, 5.0, 7.5, and 10.0 μMin 1.5mL volume)were added
to standard amount of BBP (2.0 mg/1.5 mL), after which the Z14S con-
tent of the supernatants were quantified. Data were evaluated applying
the Langmuir and Freundlich sorption isotherms [21,23]. The Langmuir




where qe is the bound amount of Z14S (mg/g BBP), Q0 represents the
maximum amount of Z14S bound (mg/g BBP), Ce denotes the free
amount of Z14S (mg) in the solution at equilibrium, and KL is the Lang-
muir equilibrium constant (L/mg). The Freundlich equation was de-
scribed as:
qe ¼ K F C1=ne ð3Þ
where n andKF are theheterogeneity index and the Freundlich constant,
respectively.
2.5. HPLC analysis
Z14S concentrations in the supernatants were quantified by an inte-
grated HPLC system (Jasco, Tokyo, Japan), which includes an
autosampler (AS-4050), a binary pump (PU-4180), and a fluorescence
detector (FP-920). A 20-μL volume of samples was driven through a
Phenomenex Security Guard™ (C18, 4.0 × 3.0 mm) guard column
joined to a Kinetex (C18, 250 × 4.6 mm, 5 μm) analytical column. The
isocratic elutionwas performedwith 1.0mL/min flow rate at room tem-
perature. The mobile phase contained methanol, acetonitrile, and dis-
tilled water (6:35:59 v/v%). Z14S was detected at 465 nm (λex =
330 nm), and the chromatograms were evaluated with ChromNAV
software.
2.6. Statistics
Statistical analyses were performed with one-way ANOVA test (IBM
SPSS, New York, NY, USA). The level of significance was set to p b 0.01.
3. Results and discussion
3.1. Fluorescence excitation and emission spectra of zearalenone-14-sulfate
First, the fluorescence excitation and emission spectra of Z14S were
recorded in different buffers (pH5.0, 7.4, and10.0; Fig. 2). The excitation
wavelength maximum of Z14S was noticed around 330 nm under
weakly acidic (pH 5.0) and physiological (pH 7.4) circumstances. How-
ever, at pH 10.0, a slight red shift of the maximum (330 nm→ 334 nm)
and a significant decrease in the fluorescence signal were noticed
(Fig. 2A). Furthermore, at pH 5.0 and 7.4, the emission spectra of theFig. 2. Fluorescence spectra of Z14S (25 μM). Excitation (A; pH 5.0 and pH7.4:λem=465 nm; p
334 nm) spectra of the mycotoxin in different buffers (0.05 M sodium acetate, pH 5.0; 0.05 M
references to colour in this figure legend, the reader is referred to the web version of this articmycotoxin were similar, while a blue shift of thewavelengthmaximum
(465 nm→ 458 nm) and the decreased emission signal were observed
at pH 10.0 (Fig. 2B). Since the protonation state can influence the ab-
sorption and fluorescence spectra of the fluorophores [34–36], these
spectral changes are likely resulted from the deprotonation of themyco-
toxin at the highest pH tested (similarly to zearalenone, zearalenols, and
zearalenone-14-glucoside [17,37,38]): The phenolic hydroxyl group of
Z14S on C16 may lose its proton under alkaline conditions.
3.2. Effects of cyclodextrins on the fluorescence emission signal of
zearalenone-14-sulfate
Fluorescence spectra of Z14S were also examined in the presence of
native β- and γ-CDs at pH 5.0. CDs induced a blue shift in the excitation
wavelength maximum of Z14S (data not shown); therefore, emission
spectrawere recorded using 320 nmexcitationwavelength. In the pres-
ence of CDs, the fluorescence emission signal of themycotoxinwas con-
siderably increased and a slight blue shift of the emission wavelength
maximum (465 nm→ 460 nm) was observed (Fig. 3). Typically, the in-
clusion of organic fluorophores by β-CDs results in a blue shift in their
fluorescence emissionwavelengthmaxima [34,35]. This fact and the ob-
servation that CDs alone did not exert significantfluorescence under the
applied conditions suggest the formation of host-guest type Z14S-CD
complexes. The fluorescence enhancement observed can be explained
by the decreased quenching effect of water molecules due to the inclu-
sion of Z14S in the nonpolar CD cavity [39,40]. BCD induced higher fluo-
rescence enhancement of the mycotoxin (Fig. 3B) and formed more
stable (approximately three-fold; see details later in Section 3.3) com-
plexes with Z14S than GCD. Thus, Z14S favors the smaller cavity of
BCD vs. GCD, similarly to zearalenone [37]. Interestingly, the masked
mycotoxin zearalenone-14-glucoside showed the opposite [17]. In the
following experiments, BCD and its chemically modified derivatives
were studied further.
3.3. Interaction of zearalenone-14-sulfate with native and chemically mod-
ified cyclodextrins in different buffers
Emission spectrum of Z14S was recorded in the presence of increas-
ing CD concentrations in different buffers. At pH 5.0, β-CDs induced 14-
to 21-fold increase in the emission signal of the mycotoxin at 460 nm
(Fig. 4 and Table 1). Monoamino- (MABCD) and dimethyl-β-CDs
(DIMEB) caused stronger while other derivatives resulted in weaker
fluorescence enhancement than the native BCD (Fig. 4). Binding con-
stants of Z14S-CD complexes were determined using the Benesi-
Hildebrand equation (Eq. (1)). Benesi-Hildebrand plots showed excel-
lent fitting (R2 = 0.990–0.999) with the 1:1 stoichiometry modelH10.0:λem=458 nm) and emission (B; pH 5.0 and pH7.4:λex= 330 nm; pH 10.0:λex=
sodium phosphate, pH 7.4; 0.05 M sodium borate, pH 10.0). (For interpretation of the
le.)
Fig. 3. Fluorescence emission spectra of Z14S (1 μM) in the presence of increasing BCD (A) and GCD (C) concentrations (0.0–2.0 mM) in 0.05 M sodium acetate buffer (pH 5.0; λex =
320 nm). (B) BCD- and GCD-induced increase in the fluorescence of Z14S (λex = 320 nm, λem = 460 nm).
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(logK= 3.6 to 4.7) at pH 5.0 (Table 1). Hydroxypropyl- (HPBCD) and
sulfobutyl-substitution (SBCD) did not affect the affinity ofβ-CD toward
Z14S; therefore, these derivatives were not tested further. MABCD and
QABCD complexes showed approximately two-fold higher binding con-
stants vs. Z14S-BCD. Furthermore, the methylated β-CDs, namely
DIMEB and RAMEB formed the most stable complexes with the myco-
toxin (approximately 11- and 5-fold compared to BCD, respectively)
(Table 1). As it has been reported, the masked mycotoxin
zearalenone-14-glucoside formed less stable complexes with BCD
(logK= 2.8) than Z14S [17]; however, the binding constants of Z14S-
BCD (logK = 3.6) and zearalenone-BCD (logK = 4.0) [37] complexes
were similar at pH 5.0. Furthermore, the stability of Z14S complexes
with RAMEB and DIMEB is practically identical to zearalenone com-
plexes; however, SBCD is less while QABCD is more suitable for the en-
trapment of Z14S compared to zearalenone [37].
The interaction of Z14S with BCD, RAMEB, DIMEB, MABCD, and
QABCD were also investigated at pH 7.4 and 10.0. The absolute fluores-
cence intensities of Z14S-CD complexes were the highest at pH 5.0 (see
in Fig. 4). Furthermore, the relative enhancement in the fluorescence of
Z14S by CDs is demonstrated in Table 1. At pH 7.4, the CD-induced rel-
ative increase in fluorescence was similar to observed at pH 5.0. Despite
the fact that the absolute intensities of Z14S-CD complexes were theFig. 4. Fluorescence emission intensities of Z14S (1 μM) in the presence of increasing CD
concentrations (0–2 mM) in 0.05 M sodium acetate buffer (pH 5.0; λex = 320 nm;
λem = 460 nm).lowest at pH 10.0 (see representative spectra in Fig. S2), the relative en-
hancement was significantly higher under these conditions (Table 1).
The only exception was Z14S-QABCD complex, which showed poor
emission signal at pH 10.0 (Fig. S2, bottom right). Under alkaline cir-
cumstances, the phenolic hydroxyl group of Z14S likely becomes
deprotonated which results in a blue shift in its emission maximum
and the significant decrease in its emission signal (see in Fig. 2). CDs
tested (except QABCD) behaved similarly and likely favor the proton-
ated form of the mycotoxin. Because the same emission wavelength
maximum (approximately at 460 nm) was observed at each pH exam-
ined, it is reasonable to hypothesize that most of the CDs formed stable
complexes with the same (protonated) form of Z14S. This hypothesis is
supported by the following observations: (1) the relative increase in the
fluorescence is larger at pH 10.0 due to the higher fluorescence signal of
protonated Z14S (since CDs produce more stable complexes with this
form, the equilibrium changes in favor of the protonated Z14S);
(2) the higher relative fluorescence enhancement accompanied with
significantly lower binding constant at pH 10.0, because CDs form com-
plexes with the protonated mycotoxin which is presumably not the
dominant form under alkaline conditions. On the other hand, QABCD
seems to favor the deprotonated form based on the following observa-
tions (Fig. S2): (1) At pH 10.0, the emission wavelength maximum of
Z14S-QABCD (447 nm) is different from the other CD complexes tested;
(2) Z14S-QABCD complex has much lower emission signal than other
complexes at pH 10.0, despite the fact that it was an effective enhancer
at pH 5.0 and 7.4; (3) Z14S-QABCD shows the highest stability at
pH 10.0. Since QABCD contains cationic substituents
(tetraalkylammonium moieties), it is reasonable to hypothesize that
its ionic interaction with the deprotonated mycotoxin may stabilize
the formed complex.
3.4. Molecular modeling studies
Z14S showed a similar mode of binding regarding β- and γ-CD
(Fig. 5), even though the capability to get sunk within the diverse cavi-
ties was found dependent on the internal radius of CDs. Specifically, the
interactionwith either BCD or DIMEBwasmore superficial, while it was
deeper within the GCD (whose internal radius is higher in comparison
to that of BCD and DIMEB). The analysis of the binding poses showed
that Z14S arranged the aliphatic ring within the hydrophobic core of
CD cavity, while it used the sulfate and keto groups to engage the
large border of the CDs with polar contacts. The binding poses calcu-
lated in the light of the affinity to CDs observed experimentally
(DIMEB ≫ BCD N GCD) suggested the stark importance of hydrophobic
interactions to stabilize the Z14S-CD complexes. Indeed, the 2-O-
methylation regarding DIMEB was thought providing an additional
Table 1
CD-induced relative increase in the fluorescence emission signal of Z14S (I/I0; 1 μMZ14S+ 2.0mMCD) in different buffers (λex= 320 nm, λem= 460 nm). Decimal logarithmic values of
binding constants (K; unit: L/mol) of Z14S-CD complexes.
I/I0 ± SEM logK ± SEM
pH 5.0 pH 7.4 pH 10.0 pH 5.0 pH 7.4 pH 10.0
BCD 18.51 ± 0.32 19.29 ± 0.50 20.24 ± 0.49 3.60 ± 0.02 3.55 ± 0.02 3.05 ± 0.02
RAMEB 16.55 ± 0.46 16.95 ± 0.21 26.49 ± 0.18 4.29 ± 0.04 4.27 ± 0.05 3.67 ± 0.04
DIMEB 20.10 ± 0.90 21.02 ± 0.79 33.31 ± 0.16 4.66 ± 0.05 4.63 ± 0.03 4.20 ± 0.08
MABCD 21.03 ± 0.11 21.76 ± 0.41 25.10 ± 0.66 3.90 ± 0.03 3.99 ± 0.05 3.04 ± 0.03
QABCD 14.77 ± 0.06 15.62 ± 0.17 6.67 ± 0.06 3.98 ± 0.03 3.74 ± 0.01 4.21 ± 0.01
HPBCD 14.25 ± 0.08 3.61 ± 0.02
SBCD 14.96 ± 0.25 3.59 ± 0.01
GCD 7.51 ± 0.05 3.14 ± 0.01
5Z. Faisal et al. / Journal of Molecular Liquids 310 (2020) 113236hydrophobic patch that could better stabilize the interaction with the
aromatic ring of Z14S in comparison to either BCD or GCD. Concerning
the diverse affinity between BCD and GCD observed experimentally, it
could be partially explained by the differential sinking of Z14S within
the two hydrophobic cavities. In particular, keeping in mind that keto
group in position #7 and the 2-oxabicyclo group represent hydrophilic
patches in the aliphatic ring of Z14S, the more superficial interaction
with BCD is likely more favored than that within GCD, wherein both
groups are deeper included within the hydrophobic core of GCD's
cavity.
3.5. Interaction of zearalenone-14-sulfate with soluble β-cyclodextrin
polymers
We also tested the interactions of the mycotoxin with soluble (epi-
chlorohydrin cross-linked) BCD and QABCD polymers at pH 5.0 and
10.0 (the soluble polymer of DIMEB is not available). The fluorescence
emission spectrum of Z14S (1 μM) was recorded in the presence of in-
creasing concentrations of soluble polymers. In order to apply compara-
ble CD concentrations with the previous investigations, the polymer
was normalized to its CD “monomer” content (0.0, 0.05, 0.1, 0.2, 0.5,Fig. 5. Interactions of Z14S with BCD, GCD, and DIMEB. (A) Representation of the calculated c
reference point and it indicates the centroid of hexose sugars of each CD: the inclusion of Z
calculated complexes in sticks. Yellow dotted lines indicate the formation of polar contacts w
receive hydrophobic, hydrogen bond donor and hydrogen bond acceptor groups, respectively
favoring the interaction with the aromatic ring of Z14S. (For interpretation of the references to1.0, and 2.0 mM). Sometimes the CD polymers have higher affinity to-
ward guest molecules due to the cooperativity of the monomers
[22,41,42]. Therefore, the binding constants of the formed complexes
were calculated based on the CD content of polymers applied
(Eq. (1)), as it has been reported previously [22]. The complexes of
Z14S with soluble BCD polymer showed 3.65 (±0.04) and 2.74 (±
0.06) logK values at pH 5.0 and 10.0, respectively. These data are in
good agreement with our previous results with the BCD monomer
(Table 1). The soluble QABCD polymer formed slightly less stable com-
plexes with Z14S at pH 10.0 (logK = 3.96 ± 0.03) than the QABCD
monomer. However, approximately three-fold higher affinity of the
polymer (logK = 4.48 ± 0.01) vs. the monomer was noticed at
pH 5.0. These observations suggest that soluble QABCD polymer is suit-
able to form highly stable complexes with Z14S at both pH 5.0 and 10.0,
in agreement with the data presented in Table 1.
3.6. Extraction of zearalenone-14-sulfate from aqueous solution by insolu-
ble (water-swellable) β-cyclodextrin bead polymer
As it has been demonstrated, insoluble CD polymers are suitable for
mycotoxin removal fromaqueous solutions, including certain beveragesomplexes in cut surfaces (CDs) and sticks (Z14S). The dashed line serves as geometrical
14S is deeper within GCD than within either BCD or DIMEB. (B) Representation of the
hile the grey, blue, and red mesh indicates regions sterically and energetically suitable to
. The red ring indicates the position of the 2-O-methylation of DIMEB, which is thought
colour in this figure legend, the reader is referred to the web version of this article.)
6 Z. Faisal et al. / Journal of Molecular Liquids 310 (2020) 113236[21,23]. Zearalenone was successfully extracted from spiked corn beer
[23] and the zearalenone-14-glucoside content of aqueous solution
was also effectively decreased by BBP [17]. Some chemically-modified
CDs have higher affinity toward Z14S than BCD; however, only the
BCD polymer is available in insoluble (water-swellable) form. There-
fore, the removal of Z14S by BBP was tested in 0.05 M sodium acetate
buffer (pH 5.0). In a concentration-dependent fashion, BBP considerably
decreased the Z14S content of the solution, resulting in 95% reduction of
themycotoxin concentration in the presence of 20.0mg/1.5mL BBP (vs.
1 μM Z14S) (Fig. 6A). Based on these results, Z14S can be extracted by
BBP with similar efficacy from aqueous solution than zearalenone [23].
In order to describe quantitatively the interaction of Z14S with BBP,
increasing Z14S concentrations were added to standard amount of BBP
(see details in Section 2.4) in sodiumacetate buffer (0.05M, pH5.0). The
binding ability of BBP was evaluated using the Langmuir (Eq. (2)) and
Freundlich (Eq. (3)) isotherms (Fig. 6B). The Langmuir affinity constant
(KL) was 0.096 ± 0.051 L/mg and the Q0 value was 9.53 ± 4.49 mg/g.
The Freundlich model showed a 0.827 ± 0.019 (mg/g) × (L/mg)1/n
Freundlich constant (KF) and a 0.895± 0.045 1/n value. KL and KF values
of Z14S-BBP interaction were lower compared to zearalenone-BBP
(KL = 0.60 L/mg, KF = 1.16 (mg/g) × (L/mg)1/n) [23], suggesting the
slightly lower adsorptive capacity of BBP regarding Z14S vs. the parent
mycotoxin. The n value suggests the relatively homogenous sorption
of Z14S to BBP.
4. Conclusions
In summary, the interaction of the modified mycotoxin Z14S with
native and chemically-modified CDs as well as with soluble CD poly-
mers was investigated. Furthermore, the extraction of Z14S from aque-
ous solution by insoluble β-CD bead polymer was examined. Z14S form
similarly stable complexes with CDs than zearalenone, and also favors
β- vs. γ-CDs. CDs induced strong increase in the fluorescence signal of
Z14S: MABCD, DIMEB, and BCD proved to be the most effective en-
hancers. The methyl derivatives (DIMEB and RAMEB) formed the
most stable complexes with Z14S at pH 5.0 and 7.4. Furthermore, at
pH 10.0, Z14S-QABCD showed similarly high stability to the Z14S-
DIMEB complex. Soluble BCD and QABCD polymers demonstrated com-
parable binding ability regarding Z14S than CDmonomers. BBP success-
fully decreased the Z14S content of aqueous solution, suggesting its
possible suitability as mycotoxin binder. Based on the above-listed ob-
servations, CD technology seems to be a promising tool to make more
sensitive the fluorescence detection of Z14S as well as to developFig. 6. (A) Removal of Z14S (1 μM in 1.5 mL volume) from aqueous solution (0.05 M sodium ac
25 °C; *p b 0.01). (B) Langmuir (solid line) and Freundlich (dashed line) isotherms for the Z14mycotoxin binders which can entrap modified mycotoxins besides the
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